Structure (Spironolactone 01)
Spironolactone Tablet, Film Coated
Product Images NDC 63629-1065
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 63629-1065). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Spironolactone 02)
Figure 2 (Spironolactone 03)
This text appears to be a chart showing results of a study on the effects of different medications on patients with diabetes. The chart includes data on various factors such as creatinine, potassium levels, and the use of beta blockers, and compares the effectiveness of spironolactone versus placebo.*
Lbl636291065
This is a description of Spironolactone tablets. Each tablet contains 50 mg of Spironolactone, USP. It is important to keep this medication out of the reach of children and store it at 20-25°C. The tablets should be dispensed in a tight, light-resistant container with a child-resistant closure. The package contains 100 tablets and comes with an NDC code of 63629-1065-1.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
